Found: 70
Select item for more details and to access through your institution.
The Growing Threat of NDM-Producing Escherichia coli With Penicillin-Binding Protein 3 Mutations in the United States—Is There a Potential Role for Durlobactam?
- Published in:
- Clinical Infectious Diseases, 2024, v. 79, n. 4, p. 834, doi. 10.1093/cid/ciae229
- By:
- Publication type:
- Article
Presence of Adequate Intravitreal Concentrations of Daptomycin After Systemic Intravenous Administration in a Patient with Endogenous Endophthalmitis.
- Published in:
- Pharmacotherapy, 2010, v. 30, n. 12, p. 1247, doi. 10.1592/phco.30.12.1247
- By:
- Publication type:
- Article
Spontaneous fungal peritonitis: a devastating complication of cirrhosis.
- Published in:
- Mycoses, 2015, v. 58, n. 7, p. 387, doi. 10.1111/myc.12321
- By:
- Publication type:
- Article
Defining the incidence and risk factors of colistin-induced acute kidney injury by KDIGO criteria.
- Published in:
- PLoS ONE, 2017, v. 12, n. 3, p. 1, doi. 10.1371/journal.pone.0173286
- By:
- Publication type:
- Article
Clinical manifestations and treatment outcomes for patients with Pseudomonas endocarditis.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 8, p. 2017, doi. 10.1093/jac/dkae205
- By:
- Publication type:
- Article
Carbapenem combination therapy versus standard of care for persistent methicillin-susceptible Staphylococcus aureus bacteraemia.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 8, p. 1990, doi. 10.1093/jac/dkae198
- By:
- Publication type:
- Article
Initial micafungin treatment does not improve outcomes compared to fluconazole treatment in immunocompromised and critically ill patients with candidaemia.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 8, p. 1877, doi. 10.1093/jac/dkae175
- By:
- Publication type:
- Article
Differential in vitro susceptibility to ampicillin/ceftriaxone combination therapy among Enterococcus faecalis infective endocarditis clinical isolates.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 4, p. 801, doi. 10.1093/jac/dkae032
- By:
- Publication type:
- Article
Serratia endocarditis: antimicrobial management strategies and clinical outcomes.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 10, p. 2457, doi. 10.1093/jac/dkad254
- By:
- Publication type:
- Article
High-level ceftazidime/avibactam resistance in Escherichia coli conferred by the novel plasmid-mediated β-lactamase CMY-185 variant.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 10, p. 2442, doi. 10.1093/jac/dkad249
- By:
- Publication type:
- Article
Early initiation of three-drug combinations for the treatment of carbapenem-resistant A. baumannii among COVID-19 patients.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 4, p. 1034, doi. 10.1093/jac/dkad042
- By:
- Publication type:
- Article
Optimal ceftazidime/avibactam dosing exposure against KPC-producing Klebsiella pneumoniae.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2022, v. 77, n. 11, p. 3130, doi. 10.1093/jac/dkac294
- By:
- Publication type:
- Article
Achievement of clinical isavuconazole blood concentrations in transplant recipients with isavuconazonium sulphate capsules administered via enteral feeding tube.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Reduced ceftazidime and ertapenem susceptibility due to production of OXA-2 in Klebsiella pneumoniae ST258.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Burden of illness in US hospitals due to carbapenem-resistant Gram-negative urinary tract infections in patients with or without bacteraemia.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Predicting the risk of nephrotoxicity in patients receiving colistimethate sodium: a multicentre, retrospective, cohort study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Fluconazole versus an echinocandin for Candida glabrata fungaemia: a retrospective cohort study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 4, p. 922, doi. 10.1093/jac/dks482
- By:
- Publication type:
- Article
In vitro activity of clindamycin, doxycycline, and trimethoprim/ sulfamethoxazole against clinical isolates of β-hemolytic Streptococcus spp. via BD Phoenix and broth microdilution.
- Published in:
- Antimicrobial Stewardship & Healthcare Epidemiology, 2023, v. 3, n. 1, p. 1, doi. 10.1017/ash.2023.515
- By:
- Publication type:
- Article
Correction to: Ceftazidime‑Avibactam in the Treatment of Patients with Bacteremia or Nosocomial Pneumonia: A Systematic Review and Meta‑analysis.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Ceftazidime-Avibactam in the Treatment of Patients with Bacteremia or Nosocomial Pneumonia: A Systematic Review and Meta-analysis.
- Published in:
- Infectious Diseases & Therapy, 2024, v. 13, n. 7, p. 1639, doi. 10.1007/s40121-024-00999-y
- By:
- Publication type:
- Article
Contemporary Perspective on the Treatment of Acinetobacter baumannii Infections: Insights from the Society of Infectious Diseases Pharmacists.
- Published in:
- Infectious Diseases & Therapy, 2021, v. 10, n. 4, p. 2177, doi. 10.1007/s40121-021-00541-4
- By:
- Publication type:
- Article
Development of Predictive Models to Inform a Novel Risk Categorization Framework for Antibiotic Resistance in Escherichia coli–Caused Uncomplicated Urinary Tract Infection.
- Published in:
- Clinical Infectious Diseases, 2024, v. 79, n. 2, p. 295, doi. 10.1093/cid/ciae171
- By:
- Publication type:
- Article
Navigating Available Treatment Options for Carbapenem-Resistant Acinetobacter baumannii-calcoaceticus Complex Infections.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, p. S179, doi. 10.1093/cid/ciad094
- By:
- Publication type:
- Article
Evolution and Transmission of Cefiderocol-Resistant Acinetobacter baumannii During an Outbreak in the Burn Intensive Care Unit.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 3, p. e1261, doi. 10.1093/cid/ciac647
- By:
- Publication type:
- Article
Cefiderocol for the Treatment of Infections Due to Metallo-B-lactamase–Producing Pathogens in the CREDIBLE-CR and APEKS-NP Phase 3 Randomized Studies.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 6, p. 1081, doi. 10.1093/cid/ciac078
- By:
- Publication type:
- Article
Evolution of Imipenem-Relebactam Resistance Following Treatment of Multidrug-Resistant Pseudomonas aeruginosa Pneumonia.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 4, p. 710, doi. 10.1093/cid/ciac097
- By:
- Publication type:
- Article
Molecular Epidemiology, Natural History, and Long-Term Outcomes of Multidrug-Resistant Enterobacterales Colonization and Infections Among Solid Organ Transplant Recipients.
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 3, p. 395, doi. 10.1093/cid/ciab427
- By:
- Publication type:
- Article
Changing Epidemiology and Decreased Mortality Associated With Carbapenem-resistant Gram-negative Bacteria, 2000–2017.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 11, p. e4521, doi. 10.1093/cid/ciaa1464
- By:
- Publication type:
- Article
Cefiderocol for the Treatment of Adult and Pediatric Patients With Cystic Fibrosis and Achromobacter xylosoxidans Infections.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 7, p. e1754, doi. 10.1093/cid/ciaa1847
- By:
- Publication type:
- Article
Isavuconazole Is as Effective as and Better Tolerated Than Voriconazole for Antifungal Prophylaxis in Lung Transplant Recipients.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 3, p. 416, doi. 10.1093/cid/ciaa652
- By:
- Publication type:
- Article
Clinical Evolution of AmpC-Mediated Ceftazidime-Avibactam and Cefiderocol Resistance in Enterobacter cloacae Complex Following Exposure to Cefepime.
- Published in:
- Clinical Infectious Diseases, 2020, v. 71, n. 10, p. 2713, doi. 10.1093/cid/ciaa355
- By:
- Publication type:
- Article
Early Experience With Meropenem-Vaborbactam for Treatment of Carbapenem-resistant Enterobacteriaceae Infections.
- Published in:
- Clinical Infectious Diseases, 2020, v. 71, n. 3, p. 667, doi. 10.1093/cid/ciz1131
- By:
- Publication type:
- Article
Fluoroquinolone Prophylaxis Selects for Meropenem-nonsusceptible Pseudomonas aeruginosa in Patients With Hematologic Malignancies and Hematopoietic Cell Transplant Recipients.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 12, p. 2045, doi. 10.1093/cid/ciy825
- By:
- Publication type:
- Article
Progress and New Challenges in Combatting the Threat of Antimicrobial Resistance: Perspective From an Infectious Diseases Pharmacist.
- Published in:
- Journal of Infectious Diseases, 2024, v. 229, n. 2, p. 303, doi. 10.1093/infdis/jiad250
- By:
- Publication type:
- Article
Stewardship-Guided T2Candida Testing Shortens Time to Antifungal Treatment and Reduces Antifungal Usage Among Medical Intensive Care Unit Patients With Septic Shock.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 11, p. 1, doi. 10.1093/ofid/ofad538
- By:
- Publication type:
- Article
Impact of Rapid Identification and Stewardship Intervention on Coagulase-Negative Staphylococcus Bloodstream Infection.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 8, p. 1, doi. 10.1093/ofid/ofad416
- By:
- Publication type:
- Article
Clindamycin Plus Vancomycin Versus Linezolid for Treatment of Necrotizing Soft Tissue Infection.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 6, p. 1, doi. 10.1093/ofid/ofad258
- By:
- Publication type:
- Article
Epidemiology and Clinical Outcomes of Non-HACEK Gram-Negative Infective Endocarditis.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 3, p. 1, doi. 10.1093/ofid/ofad052
- By:
- Publication type:
- Article
Discordance Among Antibiotic Prescription Guidelines Reflects a Lack of Clear Best Practices.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 1, p. 1, doi. 10.1093/ofid/ofaa571
- By:
- Publication type:
- Article
Plasma and Cerebrospinal Fluid Therapeutic Drug Monitoring of Ceftolozane and Tazobactam During Treatment of Multidrug-Resistant Pseudomonas aeruginosa Meningitis.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 12, p. 1, doi. 10.1093/ofid/ofaa549
- By:
- Publication type:
- Article
1709. Epidemiology of Invasive Fungal Infection (IFI) after Severe Influenza Requiring Intensive Care Unit (ICU) Admission: 10-Year Experience at a Tertiary Care Center in the United States.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S627, doi. 10.1093/ofid/ofz360.1572
- By:
- Publication type:
- Article
1580. Colistin Potentiates the In Vitro Activity of Meropenem–Vaborbactam (M/V) Against Some, but not All KPC-producing Klebsiella pneumoniae (KPC-Kp).
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S577, doi. 10.1093/ofid/ofz360.1444
- By:
- Publication type:
- Article
1458. Burden of Illness in Patients with Urinary Tract Infections With or Without Bacteremia Caused by Carbapenem-Resistant Gram-Negative Pathogens in US Hospitals (2014 to 2018).
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S533, doi. 10.1093/ofid/ofz360.1322
- By:
- Publication type:
- Article
710. In Vitro Activity and Performance of Available Susceptibility Testing Methods for Eravacycline Against Carbapenem-Resistant Enterobacteriaceae (CRE).
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S319, doi. 10.1093/ofid/ofz360.778
- By:
- Publication type:
- Article
656. Prioritizing Gram-Negative Bacteremia (GNB) Cases for Rapid Detection by β-Lactam Resistance (BLR) and Patient Outcomes.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S301, doi. 10.1093/ofid/ofz360.724
- By:
- Publication type:
- Article
605. Identification of a Novel CMY-Variant Enzyme in a Clinical Escherichia coli Strain with Treatment-Emergent Ceftazidime–Avibactam Resistance.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S283, doi. 10.1093/ofid/ofz360.674
- By:
- Publication type:
- Article
485. Clinical and Molecular Epidemiology of Carbapenem Non-susceptible Citrobacter sp.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S237, doi. 10.1093/ofid/ofz360.558
- By:
- Publication type:
- Article
246. Carbapenem-resistant Klebsiella (CRK) Bloodstream Infections (BSIs) Are Caused by Bacterial Populations That Are Genotypically and Phenotypically Diverse.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S138, doi. 10.1093/ofid/ofz360.321
- By:
- Publication type:
- Article
2667. Does Ceftazidime–Avibactam (CAZ-AVI) Improve Short- and Long-Term Outcomes Among Solid-Organ Transplant (SOT) Recipients with Carbapenem-Resistant Enterobacteriaceae (CRE) Infections?
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S934, doi. 10.1093/ofid/ofz360.2345
- By:
- Publication type:
- Article
2247. Real-world Experience with Meropenem–Vaborbactam (M/V) for Treatment of Carbapenem-Resistant Enterobacteriaceae (CRE) Infections.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S768, doi. 10.1093/ofid/ofz360.1925
- By:
- Publication type:
- Article